A prespecified sensitivity analysis, including only studies with a low risk of bias, was also undertaken
Gastritis (stomach inflammation): Wegovy may cause irritation or inflammation of the stomach lining
In a metabolism trial, semaglutide was the primary component circulating in plasma and, prior to excretion, it was metabolised by proteolytic cleavage of the peptide backbone and sequential beta-oxidation of the fatty acid side chain [4]
The decision to initiate semaglutide should be based on standard FDA-approved indicationstype 2 diabetes, chronic weight management, or cardiovascular risk reduction (Wegovy)rather than any presumed MS-specific benefits
A well-laid-out program has: Daily food and activity monitoring Portion control and reduced sugar intake Walking or aerobic activity for at least 150 minutes weekly Regular weight tracking and adjustments Lifestyle changes by themselves usually produce modest results, with most people losing 5-10% of their weight